[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100398376":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":26,"locations":34,"responsibleParty":53,"collaborators":10,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":59,"acronym":60,"eligibilityCriteria":61,"healthyVolunteers":57,"sex":62,"minAge":63,"maxAge":10,"enrollmentInfo":64,"targetDuration":67,"studyType":68,"phases":10,"briefSummary":69,"conditions":70,"keywords":10,"overallStatus":37,"whyStopped":10,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"University of Giessen","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"All lung cancer patients",null,"There will not be an intervention.",[13],"Other: All lung cancer patients.",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"All lung cancer patients.","There will be no specific interventions. All patients will receive guidelines based therapy of lung cancer and their comorbidities.",[9],[20,24],{"name":21,"affiliation":22,"role":23},"Bastian Eul, MD","JLU Giessen","PRINCIPAL_INVESTIGATOR",{"name":25,"affiliation":22,"role":23},"Khodr Tello, MD",[27,31],{"name":21,"role":28,"phone":29,"phoneExt":10,"email":30},"CONTACT","(+49) 0641\u002F985-42371","bastian.eul@innere.med.uni-giessen.de",{"name":32,"role":28,"phone":10,"phoneExt":10,"email":33},"Michael John Cekay, MD","michael.cekay@innere.med.uni-giessen.de",[35],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"University hospital Giessen","RECRUITING","Giessen","Hesse","35392","Germany","DE",{"type":44,"coordinates":45},"Point",[46,47],8.67554,50.58727,{"lat":47,"lon":46},[50,51,52],{"name":21,"role":28,"phone":10,"phoneExt":10,"email":30},{"name":32,"role":28,"phone":10,"phoneExt":10,"email":33},{"name":25,"role":23,"phone":10,"phoneExt":10,"email":10},{"type":54,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100398376","giessen-pulmonary-hypertension-in-lung-cancer-registry-100398376",false,"NCT04467333","Giessen Pulmonary Hypertension in Lung Cancer Registry","PHLHR","Inclusion Criteria:\n\n* Patient with lung cancer at the University of Giessen lung Cancer Center.\n\nExclusion Criteria:\n\n\\-","ALL","18 Years",{"count":65,"type":66},500,"ESTIMATED","3 Weeks","OBSERVATIONAL","The aim of this study is to investigate the frequency and implications of pulmonary hypertension in lung cancer patients. To do so, data will be collected from all lung cancer patients at the university hospital Giessen. All data will be analyzed for possible hints of pulmonary hypertension as a comorbidity in lung cancer patients. All information will be generated from the regular guidelines based course of treatment and there will be no interventions. This study will serve as a prospective register for all lung cancer patients treated at the university hospital Giessen.",[71],"Pulmonary Hypertension Due to Lung Diseases and Hypoxia","2025-03-26",{"date":74,"type":75},"2025-04-01","ACTUAL",{"date":77,"type":75},"2020-06-29",{"date":79,"type":66},"2040-01-29",{"name":5,"class":6},1]